Short answer
BAP1 tumor predisposition genetic testing looks for inherited pathogenic or likely pathogenic variants in BAP1. The result matters most when the personal or family pattern includes uveal melanoma, cutaneous melanoma, mesothelioma, renal cell carcinoma, BAP1-inactivated melanocytic tumors, basal cell carcinoma, or other findings that fit a hereditary tumor syndrome. A BAP1 result found only in tumor tissue is not automatically inherited, and a BAP1 VUS should not be treated like a confirmed harmful variant.
How to read the result
| Report wording | Practical meaning | What to ask next |
|---|---|---|
| Pathogenic or likely pathogenic germline BAP1 variant | The lab found an inherited BAP1 change with enough evidence to guide syndrome-level counseling. | Which eye, skin, kidney, mesothelioma, and family-testing conversations apply to this exact result? |
| BAP1 variant of uncertain significance | The lab found a BAP1 change, but its health meaning is not established. | Should care be based on personal and family history while the variant remains uncertain? |
| Negative BAP1 result | No reportable BAP1 variant was found in the test performed. | Was there a known family variant, and were other tumor-predisposition genes considered? |
| Tumor-only BAP1 finding | The BAP1 change may be present only in cancer tissue rather than inherited DNA. | Is separate germline testing needed before relatives are told they may be at inherited risk? |
| Family variant testing | Relatives may be offered targeted testing when a confirmed familial pathogenic BAP1 variant is known. | Does the report name the exact familial variant relatives should be tested for? |
Cancer-risk context to clarify
- GeneReviews and MedlinePlus describe BAP1 tumor predisposition syndrome as a pattern that can include uveal melanoma, cutaneous melanoma, mesothelioma, renal cell carcinoma, basal cell carcinoma, and BAP1-inactivated melanocytic tumors.
- NCI's definition emphasizes increased risk for cancers of the skin, eye, kidney, and mesothelium, while also noting that benign skin tumors may occur.
- A tumor pathology clue, family history, or multiple primary cancers can be the reason BAP1 is considered, but the exact testing question should be clear before relatives are tested.
- Tumor-only BAP1 alterations can help cancer teams understand a tumor, but they do not by themselves prove inherited BAP1 tumor predisposition syndrome.
- A negative result is most reassuring when the test was targeted to a known familial BAP1 variant. Without a known family variant, it may be an uninformative negative.
Questions to bring to counseling
- Was BAP1 tested from blood, saliva, cheek cells, tumor tissue, or paired tumor-normal testing?
- What is the exact BAP1 variant notation and classification?
- Does the personal or family history include uveal melanoma, mesothelioma, cutaneous melanoma, kidney cancer, or BAP1-inactivated melanocytic tumors?
- Does this result change eye exams, skin exams, kidney imaging, mesothelioma discussions, or other surveillance planning?
- Should relatives have targeted testing for a known family variant, and who should start the conversation?
- Could a tumor-only result require germline confirmation before family-risk decisions are made?
- How will I be notified if a BAP1 VUS is reclassified?
Related guides: hereditary cancer genetic testing, tumor genomic vs inherited genetic testing, PTEN hamartoma tumor syndrome genetic testing, DICER1 syndrome genetic testing, and when to use a genetic counselor.
When follow-up matters more
Follow-up matters more when the result came from tumor tissue, when the family pattern is strong enough that a negative result does not feel reassuring, or when relatives need clarification about whether a confirmed familial variant exists. Paired tumor-normal testing and genetics review can separate a tumor clue from inherited BAP1 predisposition.
What the result still cannot prove
A BAP1 result can support inherited cancer-risk counseling, but it does not by itself predict the exact tumor type, timing, or full clinical course for a person or family.
FAQ
What cancers are most associated with BAP1?
BAP1 tumor predisposition syndrome is most associated with uveal melanoma, cutaneous melanoma, mesothelioma, renal cell carcinoma, and BAP1-inactivated melanocytic tumors.
Is a tumor-only BAP1 finding inherited?
Not automatically. A tumor-only BAP1 change may help explain a tumor but does not by itself prove inherited predisposition syndrome.
Is a BAP1 VUS actionable?
No. A BAP1 variant of uncertain significance should not be treated like a confirmed harmful variant.
Does a negative BAP1 result rule out the syndrome?
Not always. A negative result is most reassuring when there is a known family variant and the test targeted that exact change.
Do relatives need targeted testing?
Yes, when a confirmed familial pathogenic BAP1 variant is known and the family is being counseled around inherited risk.
Why does specimen type matter?
Blood, saliva, cheek cells, tumor tissue, and paired tumor-normal testing answer different questions and can change how the result should be interpreted.
How can paired tumor-normal testing help with BAP1?
It can help show whether a BAP1 change is only in the tumor or also in normal DNA, which changes whether the finding should be treated as inherited risk.